However, individuals should consult healthcare providers before use, particularly if they have underlying conditions or take other medications, Dr
GLP-1 receptor agonist use was not associated with a substantially increased risk of thyroid cancer over a mean follow-up of 3.9 years, Bjrn Pasternak, MD, PhD, associate professor and principal researcher in the division of pharmacoepidemiology, department of medicine at Karolinska Institutet in Sweden, and colleagues wrote
Third, when retatrutide becomes available and you start seeing claims about it, the question to ask your doctor is not "does it work?" but "for my specific situation, what does it improve that we already know about, and what hasn't been studied yet?" Weight, blood-sugar control, and liver fat sit on strong evidence
However, this analysis only included coordinates from 7 different contrasts which is too low to make robust inferences about convergence